Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediZap is a private U.S. healthcare services company focused on terminal sterilization and related support for compounded pharmaceutical products. The company provides E-Beam and X-Ray terminal sterilization services, packaging and labeling solutions, compliance support, and access to partner laboratory and manufacturing services for compounders and small-pharma clients. MediZap positions itself as a turn-key service provider built specifically for compounded sterile products, with offerings intended to support sterility assurance, regulatory readiness, and commercialization. Its customers appear to include compounding pharmacies, outsourcing facilities, hospitals, health systems, and pharmaceutical manufacturers. The business is service-oriented rather than a therapeutic drug developer, and no proprietary clinical-stage drug pipeline is publicly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediZap.